
Medizone-XP 250mg/31.25mg Injection
Marketer
Medilente Pharma Pvt Ltd
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Medizone-XP 250mg/31.25mg Injection
Combiflox-250 is a dual-action injectable antibiotic used to combat a range of bacterial infections. Its mechanism involves inhibiting microbial growth, thereby limiting infection spread. Administration must be strictly under a doctor's guidance; adherence to the prescribed schedule is crucial for effectiveness. Completing the entire course of treatment is vital, even with symptom improvement, as premature cessation can compromise its efficacy. Potential side effects include nausea, vomiting, diarrhea, and digestive upset. Severe or worsening side effects necessitate immediate medical attention. Seek immediate medical help for allergic reactions such as rash, itching, swelling, or breathing difficulties. Inform your physician of all current medications, especially if pregnant or breastfeeding, before commencing treatment. Alcohol consumption should be avoided due to the risk of increased drowsiness. While generally not impairing driving ability, refrain from driving if experiencing drowsiness or dizziness. Adequate rest, a balanced diet, and sufficient hydration contribute to faster recovery. Your doctor may order lab tests to monitor your response to the medication.
Primary Ingredients of Medizone-XP 250mg/31.25mg Injection
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Medizone-XP 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Medizone-XP 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is not recommended.
Common Side effects of Medizone-XP 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Medizone-XP 250mg/31.25mg Injection:
Administering this medication will be performed by your physician or their designated nurse; self-medication is strictly prohibited.
How Medizone-XP 250mg/31.25mg Injection works:
Ceftriaxone/Tazobactam Injection (Medizone-XP 250mg/31.25mg) unites a cephalosporin antibiotic, Ceftriaxone, with a beta-lactamase inhibitor, Tazobactam. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, hindering their ability to reproduce. Tazobactam counters bacterial resistance mechanisms, thereby bolstering Ceftriaxone's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
Medizone-XP 250mg/31.25mg Injection can be used concurrently with alcohol without adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable formulation Medizone-XP (250mg/31.25mg) is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or absent harm to the fetus; nevertheless, clinical data from human studies are scarce.
Breast feedingCAUTION
Administering Medizone-XP 250mg/31.25mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Medizone-XP 250mg/31.25mg Injection might induce drowsiness, blurred vision, or dizziness. Refrain from operating a vehicle should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Medizone-XP 250mg/31.25mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Exercise caution when administering Medizone-XP 250mg/31.25mg Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage alterations for Medizone-XP 250mg/31.25mg Injection are unnecessary for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Medizone-XP 250mg/31.25mg Injection :
Should you forget a scheduled dose of Medizone-XP 250mg/31.25mg Injection, seek advice from your physician.
Facts to Know About Medizone-XP 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
